1005-0108
2012 Issue 5
Synthesis and antioxidant activities of 5,7,4′-tri(hydroxyl) isoflavonyl-8-azophenylsulfonic acid
L Sha-sha;LI Li-ping;XU Shuang;GUO Rong;YAN Xi
L Sha-sha;LI Li-ping;XU Shuang;GUO Rong;YAN Xi
..............page:364-368
yao wu she ji ce lue shu ping
you qi dong
you qi dong
..............page:355
..............page:459
Progress in angiotensin receptor as drug targets
ZHANG Zhi-chao;CAI Tian-cheng;MA Zu-xiao;SUN Tie-min
ZHANG Zhi-chao;CAI Tian-cheng;MA Zu-xiao;SUN Tie-min
..............page:442-451
Progress in antidiabetics based on GPR119
ZHAO Li-xia;YU Yang;WANG Zhi-qiang;SUN Tie-min
ZHAO Li-xia;YU Yang;WANG Zhi-qiang;SUN Tie-min
..............page:393-402
florbetapir 18f
zhao wen fang dong jin hua
zhao wen fang dong jin hua
..............page:457
Progress on cholesterol synthesis inhibitors as anti-atherosclerosis agents
LIANG Da-wei;CAO Liang;DONG Jin-hua
LIANG Da-wei;CAO Liang;DONG Jin-hua
..............page:432-441
avanafil
xu hui lan hu chun
xu hui lan hu chun
..............page:458
Recent advances in novel non-purine selective inhibitors of xanthine oxidase for the treatment of hyperuricemia and gout
ZHAN Peng;LIU Tao;LIU Xin-yong; School of Pharmacy;Shandong University;Ji′nan 250012;China)
ZHAN Peng;LIU Tao;LIU Xin-yong; School of Pharmacy;Shandong University;Ji′nan 250012;China)
..............page:403-415
Improved synthesis of antipodagri febuxostat
XIE Peng;ZHANG Jin;JIN Hua;LI Jian-qi;ZHOU Bin
XIE Peng;ZHANG Jin;JIN Hua;LI Jian-qi;ZHOU Bin
..............page:369-372
Advances in research of gout and its therapeutic drugs
XIN Ya-wen;ZENG Zheng-ying;CHEN Guo-liang
XIN Ya-wen;ZENG Zheng-ying;CHEN Guo-liang
..............page:416-423
..............page:392
Clinical application of therapeutic drugs of fatty liver
SONG Jian;ZHANG Mu-xin;SUN Wei;YANG Xiao-hong;ZHOU Xiao-ping
SONG Jian;ZHANG Mu-xin;SUN Wei;YANG Xiao-hong;ZHOU Xiao-ping
..............page:452-456
Synthesis of the key intermediate of type 2 diabetes drug sitagliptin
LIU Ying-shuai;WANG Yan-ping;GUO Jin-cai;ZHANG Xing-xian
LIU Ying-shuai;WANG Yan-ping;GUO Jin-cai;ZHANG Xing-xian
..............page:360-363
Synthesis and hypoglycemic activity of 5-hydroxylmethyl-2-furfural derivatives
ZHANG Xin1;LIAO Xiang-wei2;WU Song2;DU Guan-hua2;HAO Ling-hua2
ZHANG Xin1;LIAO Xiang-wei2;WU Song2;DU Guan-hua2;HAO Ling-hua2
..............page:349-355
..............page:459
Recent advances in peptidomimetic dipeptidyl peptidase Ⅳ inhibitors
LIU Yang;LIU Tao;HU Yong-zhou
LIU Yang;LIU Tao;HU Yong-zhou
..............page:373-381
Design,synthesis and α-glucosidase inhibitory activity of 5-(p-toluenesulfonylamino) phthalimide derivatives
BIAN Xiao-li1;WANG Qian2;LUO Zhen-ji1;FAN Xiang-ni1
BIAN Xiao-li1;WANG Qian2;LUO Zhen-ji1;FAN Xiang-ni1
..............page:341-348
Research progress in nicotinic acid receptor GPR109a and related agonists
KE Chang-hu;BIAN Xiao-li
KE Chang-hu;BIAN Xiao-li
..............page:424-431,451
Synthesis of G protein-coupled receptor 119 agonist MBX-2982
DING Lu;LUO Tang;SONG Kai-zhen;GONG Ping;HAN Jing
DING Lu;LUO Tang;SONG Kai-zhen;GONG Ping;HAN Jing
..............page:356-359
Research progress of dipeptidyl peptidase Ⅳ inhibitors
LI Qing;LI Hui;ZHOU Jin-pei;ZHANG Hui-bin
LI Qing;LI Hui;ZHOU Jin-pei;ZHANG Hui-bin
..............page:382-392
..............page:459